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Abstract
Background: A delay in the diagnosis and treatment of tuberculosis meningitis (TBM) may lead to increased
mortality and morbidity. The aim of this study was to describe the clinical, radiological and laboratory findings of
TBM on a cohort of 185 pediatric patients at a single centre over a 10 year period and to investigate relationship
between the stage of the disease.
Methods: The hospital records of 185 TBM children that presented to the Pediatric Clinics of Dicle University
Hospital were retrospectively evaluated. The age, gender, family history of tuberculosis, result of Mantoux skin
test, status of BCG vaccination, stage of TBM at hospitalization, and clinical, laboratory and radiological features
were recorded. Clinical staging of TBM was defined as follows: Stage I, no focal neurological findings and Glasgow
Coma Scale (GCS) score 15; Stage II, GCS 15 presenting with focal neurological deficit or all the patients with GCS 10–14;
Stage III, all the patients with GCS < 10. Relationships between results and stages of TBM were investigated.
Results: The mean age of the patients was 53.5 ± 44.9 months (4 months–18 years). 121 (65.4 %) of the patients
were male and 64 (34.6 %) female. Family history of tuberculosis was defined in 62 (33.5 %) patients. Forty five
(24.3 %) children had BCG vaccination scar. Mantoux skin test was interpreted as positive in 35 (18.9 %) patients.
Sixty-eight (36.8 %) children were at stage I TBM, 57 (30.8 %) at stage II and 60 (32.4 %) were at stage III on admission.
Mean duration of hospitalization was 23.9 ± 14.1 days. Totally, 90 patients (48.6 %) had abnormal chest X-ray findings
(parenchymal infiltration in 46 (24.9 %), mediastinal lymphadenopathy in 36 (19.5 %), miliary opacities in 25 (13.5 %),
pleural effusion in 2 (1.1 %), and atelectasis in 2 (1.1 %) patients). One hundred sixty seven (90.3 %) patients had
hydrocephalus in cranial computerized tomography. There were 24 (13.0 %) patients with positive culture for
Mycobacterium tuberculosis and 3 (1.6 %) patients with positive acid-fast bacilli in cerebrospinal fluid. Overall
mortality rate was 24 (13.0 %). Among the findings; patients at Stage III had less frequent positive chest X-ray
abnormality, miliary opacities and BCG vaccination scar when compared with patients at Stage I and II (p = 0,005;
p = 0,007, p = 0.020, respectively).
Conclusions: Children with TBM and positive chest X-ray findings at hospital admission were more frequently
diagnosed at Stage I, and BCG vaccination might be protective from the Stage III of the disease.
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Introduction
According to the World Health Organization, in 2013,
approximately 9 million cases of tuberculosis (TB) were
detected with 1.5 million of them resulting in death. Ap-
proximately 10 % of these patients were children and
15 % of these patients presented with extra pulmonary
tuberculosis [1]. Central nervous system tuberculosis is
an extra-pulmonary tuberculosis with higher mortality
and morbidity. Tuberculosis meningitis (TBM) is the
most frequently observed form of central nervous sys-
tem TB [2]. Although, TBM can be treated completely
by early diagnosis and treatment, three quarters of the
patients die if treatment is delayed [3]. The definitive
diagnosis of TBM is established by the detection and/or
the culture of Mycobacterium tuberculosis in the cere-
brospinal fluid (CSF) [4]. The necessity of long time for
Mycobacterium growth on specific culture medium and
the low possibility of direct Mycobacterium identification
with CSF smear staining may lead to the delay in diag-
nosis. In order to prevent the delays in identification, the
utilization of auxiliary identification techniques such as
nucleic acid amplification (NAA), Polymerase Chain
Reaction (PCR), antibody detection, and antigen de-
tection have been used [4, 5]. Diagnostic algorithms
have been tried to implement by using some clinical,
laboratory and imaging data, especially in developing
countries, where the auxiliary diagnosis techniques are ex-
pensive and mostly inaccessible [4]. Tuberculous meningi-
tis mostly develops within 2–6 months following primary
pulmonary infections during childhood [6]. Therefore, the
determination of pulmonary TB findings may be useful
for the early diagnosis of TBM [4]. Interpretation of epi-
demiological, clinical, laboratory and radiological findings
among a large series of patients with TBM may be benefi-
cial for the early diagnosis of the disease. This presented
study aimed to describe the clinical, laboratory and
radiological features of 185 pediatric patients with
TBM hospitalized at our clinics over a 10 year period
and to investigate the relationship of these features
between the stages of the disease.
Methods
The hospital records of children admitted to the De-
partment of Pediatrics of Dicle University Hospital in
Diyarbakir Turkey between 1998 and 2008 and diag-
nosed as TBM have been evaluated retrospectively.
Twelve patients were excluded due to insufficient data
in their files, therefore 185 children were assessed.
Age, gender family history of TB, clinical, laboratory,
and radiological findings, Mantoux skin test results,
Bacillus Calmette-Guerin (BCG) vaccination status
and the history of close contact with TB disease were
recorded. Mantoux skin test was considered positive
in patients with endurance diameter > 15 mm in BCG
scar positive patients and > 10 mm in BCG scar negative
patients [7]. The chest X-rays of the patients were evalu-
ated by a pediatrician. Patients with mediastinal lymph-
adenopathy, parenchymal infiltration, and miliary opacities
were evaluated favor of TB. All patients were performed
cranial computed tomography (CT) to diagnose possible
ventricular enlargement. Diagnosis of TBM was done ac-
cording to ‘Uniform TBM resource case definition’ criteria
(Table 1) [4]. The patients who did not fulfill the criteria,
age of < 1 month and > 18 years have been excluded from
the study. The determination of the clinic stages of TBM
was done according to the criteria of Medical Research
Council [8] as follows: Stage I, patients with no focal neuro-
logical findings and Glasgow Coma Scale (GCS) score
15;Stage II, patients with GCS 15 that presenting with focal
neurological deficit or all the patients with GCS between 10
and 14, regardless of the presence of focal neurological def-
icit; Stage III, all the patients with GCS < 10. Cerebrospinal
fluid, fasting gastric juice and sputum were obtained for
acid-fast bacilli (AFB) stain and culture. Lowenstein-
Jensen medium was used for culture. The study protocol
was approved by the Non-interventional Ethical Commit-
tee of Dicle University Medical School.
Statistical analysis
Data was presented as mean plus/minus standard devi-
ation or number and percentages. Comparison of sub-
groups were done by Chi-square test. P value less than
0.05 was accepted as statistically significant.
Results
Among the 185 patients enrolled to the study, 121
(65.4 %) were boys and 64 (34.6 %) were girls. The mean
age of the patients was 53.5 ± 44.9 months (range:
4 months – 18 years). A history of close contact with an
adult TB was reported in 62 patients (33.5 %). Thirty-
five patients (18.9 %) presented with positive Mantoux
skin test result, and 45 patients (24.3 %) presented with
positive BCG vaccination status (38.5 % in Stage I,
46.2 % in Stage II and 15.4 % in Stage III; P = 0.020).
The most frequent preadmission symptoms were fever
in 144 patients (78.7 %) and vomiting in 124 patients
(70.1 %). Sixty-eight (36.8 %) children were at stage I
TBM, 57 (30.8 %) at stage II and 60 (32.4 %) were at
stage III on admission.
In cranial CT, hydrocephaly was found in 167 pa-
tients (90.3 %). Twelve (6.6 %) patients presented with
tuberculoma. The chest X-ray imaging revealed abnor-
mal imaging findings in 90 (48.6 %) patients (parenchy-
mal infiltration in 46 (24.9 %), lymphadenopathy in 36
(19.5 %), miliary opacities in 25 (13.5 %), pleural effusion
in 2 (1.1 %), and atelectasis in 2 (1.1 %) patients). Pulmon-
ary hilar lymphadenopathy was observed in 21(11.4 %),
paratracheal lymphadenopathy in 10 (5.4 %), subcarinal
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lymphadenopathy in 3(1.6 %) and paraaortic lymphaden-
opathy in two patients (1.1 %). Among the patients with
miliary opacities, 64.0 % were at stage I (P = 0.007).
There were 24 (13.0 %) patients with positive culture for
MTb, 3 (1.6 %) patients with positive AFB in cerebrospinal
fluid and 1 (0.5 %) patient with positive AFB in fasting
gastric juice. Nine patients (4.8 %) had positive polymerase
chain reaction (PCR) for MTb in CSF.
Above clinical, laboratory and radiological findings
were compared between patients at different stages of
the disease (Tables 2, 3, 4). Patients at Stage III had
less frequent positive chest X-ray abnormality, miliary
opacities and BCG vaccination scar when compared
with the patients at Stage I and II (P = 0,005; P =
0,007, P = 0.020 respectively).
Anti-tuberculous therapy including isoniazid and rifam-
pin were used for a total of 12 months together with an
initial treatment of streptomycin, pyrazinamide or etham-
butol for the first 2 months of treatment. Steroid was
given to all patient in the first month tapered by the fol-
lowing days of treatment and other measures including
mannitol and anticonvulsants were administered when
necessary. Mean duration of hospitalization was 23.9 ±
14.1 days, and twenty-four patients (13.0 %) died during
the follow-up.
Discussion
In TBM patients, early diagnosis and adequate treatment
are the most important factors that affect mortality and
morbidity rates. The definitive diagnosis of TBM is made
Table 1 Diagnostic criteria for classification of definite, probable, possible, and not tuberculous meningitis4
Diagnostic score
Clinical criteria (Maximum category score = 6)
Symptom duration > 5 days 4
Systemic symptoms suggestive of TB (one or more of the following): weight loss
(or poor weight gain in children), night sweats, or persistent cough > 2 weeks
2
History of recent (within past year) close contact with an individual with pulmonary
TB or a positive TST or IGRA (only in children <10 years of age)
2
Focal neurological deficit (excluding cranial nerve palsies) 1
Cranial nerve palsy 1
Altered consciousness 1
CSF criteria (Maximum category score = 4)
Clear appearance 1
Cells: 10–500 per μl 1
Lymphocytic predominance (>50 %) 1
Protein concentration > 1 g/L 1
CSF to plasma glucose ratio < 50 % or an absolute CSF glucose concentration
< 2.2 mmol/L
1
Cerebral imaging criteria (Maximum category score = 6)
Hydrocephalus 1
Basal meningeal enhancement 2
Tuberculoma 2
Infarct 1
Pre-contrast basal hyperdensity 2
Evidence of TB elsewhere (Maximum category score = 4)
Chest radiograph suggestive of
active TB: signs of TB = 2; miliary TB = 4
2/4
CT/ MRI/ ultrasound evidence for TB outside the CNS 2
AFB identified or M.tuberculosis cultured from another source—ie, sputum,
lymph node, gastric washing, urine, blood culture
4
Positive commercial M.tuberculosis TB NAAT from extra-neural specimen 4
Exclusion of alternative diagnoses: An alternative diagnosis must be confirmed microbiologically (by stain, culture, or NAAT when appropriate), serologically
(eg, syphilis), or histopathologically (eg, lymphoma). The list of alternative diagnoses that should be considered, dependent upon age, immune status, and
geographical region, include: pyogenic bacterial meningitis, cryptococcal meningitis, syphilitic meningitis, viral meningo-encephalitis, cerebral malaria, parasitic
or eosinophilic meningitis (Angiostrongylus cantonesis, Gnathostoma spinigerum, toxocariasis, cysticercosis), cerebral toxoplasmosis and bacterial brain abscess
(space-occupying lesion on cerebral imaging)and malignancy (eg, lymphoma) TB tuberculosis, TST tuberculin skin test, IGRA interferon-gamma release assay, NAAT
nucleic acid amplification test, AFB acid-fast bacilli
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by the growth of the bacteria in Lowenstein-Jansen solid
medium culture and/or the observation of ARB in CSF
with the microscopic examination of CSF smear identi-
fied by Erlich-Ziehl-Nielsen stain. The rates of direct ob-
servation of bacteria and/or the bacterial growth in
culture present important differences in the literature
[9]. The positive culture result depends on the repeating
puncture number, the amount of CSF taken, and the
capability of laboratory conditions [4, 10]. In previous
studies, the ratio of positive culture for M. tuberculosis
from CSF varies between 10-71 % [10–12]. In our
present study, the ratio of positive CSF culture for M. tu-
berculosis was 13 % in TBM patients. The sum of posi-
tive culture result, ARB direct visualization in stained
CSF smear, and positive PCR ratio was 20.0 % in our pa-
tients. The low rate of positive CSF culture and direct
visualization of ARB may be related to low number of
repeated lumbar puncture and small amount of CSF ob-
tained. Because, the number of repeating lumbar punc-
ture and the collection of big amount of CSF is not
always possible in children. Therefore, the utilization of
different diagnostic modalities such as nucleic acid
amplification (NAA) method, PCR, antibody detection,
antigen detection, adenosine deaminase (ADA), and
tuberculostearic acid measurement are recommended
[13]. As the access to these auxiliary methods may be
difficult, their utilization is relatively limited in develop-
ing countries where TBM is quite prevalent. As a result,
these limitations may lead to the diagnosis of the TBM
disease at later stages. In order to prevent diagnostic
delays, attempts have been made to create diagnostic
rules based on clinical, laboratory and radiological ob-
servations [4]. One hundred eight (% 58.4) of our pa-
tients were under 5 years of age. Nonspecific but
consistent clinical, laboratory and radiological findings
should be more carefully evaluated below 5 years this
age. One hundred twenty one (65.4 %) of the patients
were male and there was a family history of tubercu-
losis in 62 patients. Mantoux skin test is a significant
diagnostic method for childhood tuberculosis and it
was found positive in only 35 (18.9 %) of our patients.
The most frequent preadmission symptoms were fever
(78.7 %) and vomiting (70.1 %). Although HIV serology
tests were absent in our patients, HIV infection was not
suggested as a predisposan factor in our patients, be-
cause of the very low prevalence of HIV in children and
even in adults in Turkey, and especially in our region.
In most studies, three quarters of the patients were at
stage II or III and those results have supported delaying
in diagnosis [5, 14–16]. In a previously reported review
of 214 children with TBM at our unit in the past decade
during 1998 and 2006, there were 22 (10 %) patients in
Stage I, 120 (56 %) patients in Stage II and 72 (34 %) pa-
tients in Stage III [17]; while in our present study there
were 68 (37 %) patients in Stage I, 57 (31 %) patients in
Stage II and 60 (32 %) patients in Stage III of the disease.
In comparison of these two study periods (1988–1996
and 1998–2008), according to new policies of Ministry
Table 3 Relationship between clinical stage of tuberculosis meningitis and chest radiography findings
Chest radiography findings Stage I Stage II Stage III p
(n = 68) n (%) (n = 57) n (%) (n = 60) n (%)
Abnormal chest radiography 40 (44.4) 31 (34.4) 19 (21.1) 0.005
Parenchymal involvement 18 (39.1) 18 (39.1) 10 (21.7) NS
Miliary opacities 16 (64.0) 6 (24.0) 3 (12.0) 0.007
Mediastinal lymphadenopathy 14 (38.9) 11 (30.6) 11 (30.6) NS
Atelectasis 1 (50.0) 0 (0.0) 1 (50.0) NS
Pleural effusion 0 (0.0) 0 (0.0) 2 (100.0) NS
NS not significant
Table 2 Relationship between clinical stage of tuberculosis meningitis and laboratory findings
Stage 1 Stage 2 Stage 3 p
Mean ± standard deviation Mean ± standard deviation Mean ± standard deviation
Blood leukocytes (mm3) 12.2 ± 5.6 14.3 ± 9.7 13.4 ± 7.6 0.770
ESR (mm/hour) 43.5 ± 32.6 36.5 ± 22.5 41.0 ± 25.6 0.863
Serum Sodium level (mEq/L) 132.7 ± 7.4 128.9 ± 8.5 131.4 ± 7.6 0.198
CSF protein (mg/dl) 96.9 ± 105.7 93.9 ± 105.6 122.99 ± 122.9 0.075
CSF/serum glucose (mg/dl) 0.47 ± 0.19 0.27 ± 0.14 0.27 ± 0.13 0.054
CSF leukocytes count (/mm3) 239.5 ± 232.1 253.3 ± 263.9 212.8 ± 223.8 0.330
Hemoglobine (gr/dl) 11.1 ± 2.3 10.9 ± 1.8 10.8 ± 1.9 0.709
ESR erythrocyte sedimentation rate, CSF cerebrospinal fluid
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of Health, people could reach more advanced health fa-
cilities, there was more awareness of infectious diseases
and vaccination policies were more strict. Because of the
above reasons, in comparison with the previous study,
there were more patients diagnosed at Stage I (37 % vs
10 %). There were also more patients with positive BCG
vaccination in our series than the previos one (24 % vs
12 %). In our patients there was statistically significant
difference between the stages of the disease regarding
BCG vaccination status (38.5 % positive in Stage I,
46.2 % in Stage II and 15.4 % in Stage III; P = 0.020).
The protection rate of BCG vaccination in tuberculosis
disease is not well known (0 % to 80 %), but its role
against severe forms of tuberculosis including TBM and
miliary tuberculosis has generally been accepted [18].
The relatively low incidence of patients with BCG scar
in Stage III patients in our study could also suggest that
BCG vaccination might be protective from the more se-
vere Stage III of TBM.
Chest radiography findings (especially miliary tuber-
culosis) are among the diagnostic criteria used for diag-
nosis of TBM in clinical studies [10]. In previous
studies, ratios and types of abnormal chest X-ray find-
ings in TBM patients showed considerable differences.
While the chest X-ray findings favoring pulmonary TB
were found in 66 % and 60 % of TBM patients in differ-
ent studies [5, 19], in a recent prospective study the
conclusion was that the majority of the children with
TBM, including the very young, did not have signs sug-
gestive of TB on chest x-ray [20]. Approximately half of
our patients (52 %) did not have chest X-ray abcormal-
ities. There were parenchymal infiltration in 24.9 %,
lymphadenopathy in 19.5 %, miliary opacities in 13.5 %,
pleural effusion in 1.1 %, and atelectasis in 1.1 % of our
patients. Lymphadenopathy might have been overlooked
being superposed on pulmonary parenchymal infiltration.
Thorax computed tomography has been reported to be
more sensitive to show lymphadenopathy [21].
Definitely, chest X-ray alone is insufficient in diag-
nosing early TBM. However especially milliary opaci-
ties is an established risk factor for TBM. A previous
study showed TBM in approximately one third of the
patients with miliary tuberculosis [22]. Another post-
mortem study reported that miliary tuberculosis was
present in most of the TBM patients [23]. Among our
patients with miliary opacities, 64.0 % were at stage I
(P = 0.007). Moreover, significantly higher ratio of ab-
normal chest radiography findings was found in stage I
TBM patients while comparing with stage II and III pa-
tients in the present study. More focus should be
needed for diagnosis of tuberculosis in patients with
neurological symptoms at Stage III TBM, since these
patients had less frequent signs of pulmonary tubercu-
losis on radiography.
A standart anti-tuberculous treatment including iso-
niazid and rifampin for 12 months, and an additional
initial treatment of streptomycin, pyrazinamide or eth-
ambutol for the first 2 months were given to all patients
together with glucocorticoid therapy for the first month
tapered on the following days. Hydrocephaly was found
in 87 % patients. Mannitol, anticonvulsant therapy and
surgical management were applied when necessary.
Overall mortality rate was 13 % in our series, less than
the previously reported series in our department (23 %),
although there was no change on the treatment strategy.
Conclusion
Children with TBM and positive chest X-ray findings at
hospital admission were more frequently diagnosed at
Stage I, and patients at Stage I had more frequent BCG
vaccination scar in our study. Diagnosis of patients with
TBM at earlier stages is crucially important to decrease
mortality rates besides appropriate treatment strategies.
More focus of the doctors on diagnosis of tuberculosis
when patients presenting with early neurological symp-
toms of meningitis without abnormal chest x-ray find-
ings are encountered and increasing BCG vaccination
availability of the patients might increase number of pa-
tients diagnosed at earlier stages of TBM.
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Table 4 Relationship between clinical stage of tuberculosis
meningitis and clinical findings
Clinical
findings
Stage I Stage II Stage III p
(n = 68) n (%) (n = 57) n (%) (n = 60) n (%)
Neck rigidity 40 (21.6) 36 (19.6) 30 (16.2) 0.168
Vomiting 36 (19.5) 42 (22.7) 43 (23.2) 0.922
Fever 41 (22.2) 50 (27.0) 51 (27.6) 0.720
Headache 25 (13.5) 20 (10.8) 17 (9.2) 0.062
Consciousness 1 (0.5) 62 (33.5) 67 (36.2) <0.001
Convulsion 16 (8.7) 25 (13.5) 41 (22.2) 0.001
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